Autocrine function of inducible nitric oxide synthase and cyclooxygenase-2 in proliferation of human and rat pulmonary artery smooth-muscle cells: Species variation

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 1, 1999, Pages 105-110

  Jourdan, Karen B ^a   Evans, Timothy W ^a   Lamb, Nick J ^a   Goldstraw, Peter ^a   Mitchell, Jane A ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; AMINOGUANIDINE; CICAPROST; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DRUG DERIVATIVE; GUANIDINE DERIVATIVE; INDAN DERIVATIVE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; ISOENZYME; MEMBRANE PROTEIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; NOS2A PROTEIN, HUMAN; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; PULMONARY ARTERY; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL DIVISION; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EPOPROSTENOL; GUANIDINES; HUMANS; INDANS; INDOMETHACIN; INTERLEUKIN-1; ISOENZYMES; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PULMONARY ARTERY; RATS;

EID: 0033163137     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.1.3502     Document Type: Article

References (36)

1. Libby, P., S. J. Warner, and G. B. Friedman. 1988. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin. Invest. 81:487-498.
2. Schror, K., and A. A. Weber. 1997. Roles of vasodilatory prostaglandins in mitogenesis of vascular smooth muscle cells. Agents Actions Suppl. 48:63-91.
3. Yan, Z., and G. K. Hansson. 1998. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ. Res. 82:21-29.
4. Rizvi, M. A., and P. R. Myers. 1997. Nitric oxide modulates basal and endothein-induced coronary artery vascular smooth muscle cell proliferation and collagen levels. J. Mol. Cell. Cardiol. 29:1779-1789.
5. Gansauge, S., F. Gansauge, A. K. Nussler, B. Rau, B. Poch, M. H. Schoenberg, and H. G. Beger. 1997. Exogenous, but not endogenous, nitric oxide increases proliferation rates in senescent human fibroblasts. FEBS Lett. 410:160-164.
6. Humbert, M., G. Monti, F. Brenot, O. Sitbon, A. Portier, L. Grangeot-Keros, P. Duroux, P. Galanaud, G. Simonneau, and D. Emilie. 1995. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 151:1628-1631.
7. Voelkel, N. F., and R. M. Tuder. 1995. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hyertension. Eur. Respir. J. 8: 2129-2138.
8. Rubin, L. J. 1997. Primary pulmonary hypertension. N. Engl. J. Med. 336: 111-117.
9. McLaughlin, V. V., D. E. Genthner, M. M. Panella, and S. Rich. 1998. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N. Engl. J. Med. 338:273-277.
10. Jourdan, K. B., T. W. Evans, and J. A. Mitchell. 1998. Interleukin-1β inhibits proliferation of human pulmonary artery smooth muscle cells via a cyclooxygenase-2 dependent pathway. Br. J. Pharmacol. 123:45P. (Abstr.)
11. Jourdan, K. B., J. A. Mitchell, and T. W. Evans. 1998. Interleukin-1β inhibits proliferation of rat pulmonary artery smooth muscle cells through a nitric oxide dependent pathway. Br. J. Pharmacol. 123:46P. (Abstr.)
12. Greiss, J. P. 1864. On a new series of bodies in which nitrogen is substituted for a hydrogen. Philos. Trans. R. Soc. Lond. 154:667-731.
13. Mitchell, J. A., P. Akarasereenont, C. Thiemermann, R. J. Flower, and J. R. Vane. 1993. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA 90:11693-11697.
14. Chan, C., S. Boyce, C. Brideau, A. W. Ford-Hutchinson, R. Gordon, D. Guay, R. G. Hill, C. Li, J. Mancini, M. Penneton, P. Prasit, R. Rasori, D. Riendeau, P. Roy, P. Tagari, P. Vickers, E. Wong, and I. W. Rodger. 1995. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J. Pharmacol. Exp. Ther. 274:1531-1537.
15. Griffiths, M. J., M. Messent, N. P. Curzen, and T. W. Evans. 1995. Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med. 152:1599-1604.
16. French, J. F., L. E. Lambert, and R. C. Dage. 1991. Nitric oxide synthase inhibitors inhibit interleukin-1β-induced depression of vascular smooth muscle. J. Pharmacol. Exp. Ther. 259:260-264.
17. Beasley, D., J. H. Schwartz, and B. M. Brenner. 1991. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87:602-608.
18. Muniyappa, R., P. R. Srinivas, J. L. Ram, M. F. Walsh, and J. R. Sowers. 1998. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension 31:289-295.
19. Kessler, P., N. Kronemann, M. Hecker, R. Busse, and V. B. Schini-Kerth. 1997. Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle. J. Cardiovasc. Pharmacol. 30:802-810.
20. Griffiths, M. J., S. Liu, N. P. Curzen, M. Messent, and T. W. Evans. 1995. In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. Am. J. Physiol. 268:L509-L518.
21. Cornwell, T. L., E. Arnold, N. J. Boerth, and T. M. Lincoln. 1994. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 267:C1405-C1413.
22. Peiro, C., J. Redondo, M. A. Rodriguez-Martinez, J. Angulo, J. Marin, and C. F. Sanchez-Ferrer. 1995. Influence of endothelium on cultured vascular smooth muscle cell proliferation. Hypertension 25:748-751.
23. Geller, D. A., C. J. Lowenstein, R. A. Shapiro, A. K. Nussler, M. Di Silvio, S. C. Wang, D. K. Nakayama, R. L. Simmons, S. H. Snyder, and T. R. Billiar. 1993. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 90:3491-3495.
24. Bornfeldt, K. E., J. S. Campbell, H. Koyama, G. M. Argast, C. C. Leslie, E. W. Raines, E. G. Krebs, and R. Ross. 1997. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells: dependence on the availability of downstream targets. J. Clin. Invest. 100:875-885.
25. Mitchell, J. A., S. Larkin, and T. J. Williams. 1995. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem. Pharmacol. 50:1535-1542.
26. Stadler, J., M. Stefanovic-Racic, T. R. Billiar, R. D. Curran, L. A. McIntyre, H. I. Georgescu, R. L. Simmons, and C. H. Evans. 1991. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol. 147:3915-3920.
27. Stadler, J., B. G. Harbrecht, M. Di Silvio, R. Curran, M. Jordan, R. Simmons, and T. R. Billiar. 1993. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by kupffer cell. J. Leukoc. Biol. 65:165-172.
28. 2 production by vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 194:420-424.
29. Salvemini, D., T. P. Misko, J. L. Masferrer, K. R. Seibert, D. Currie, and P. Needleman. 1993. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90:7240-7244.
30. Swierkosz, T. A., J. A. Mitchell, T. D. Warner, R. M. Botting, and J. R. Vane. 1995. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids, Br. J. Pharmacol. 114:1335-1342.
31. Marrota, P., L. Sautebin, and M. DiRosa. 1992. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774.2. Br. J. Pharmacol. 107:640-641.
32. Kolyada, A. Y., N. Savikovsky, and N. E. Madias. 1996. Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity. Biochem. Biophys. Res. Commun. 220:600-605.
33. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc. Natl. Acad. Sci. USA 91:12168-12172.
34. Bishop-Bailey, D., S. W. Larkin, T. D. Warner, G. Chen, and J. A. Mitchell. 1997. Characterization of the induction of nitric oxide synthase and cyclooxygenase in rat aorta in organ culture. Br. J. Pharmacol. 121:125-133.
35. Jourdan, K. B., J. A. Mitchell, and T. W. Evans. 1997. Release of isoprostanes by human pulmonary artery on organ culture: a cyclooxygenase and nitric oxide dependent pathway. Biochem. Biophys. Res. Commun. 233:668-672.
36. Wilborn, J., L. J. Crofford, M. D. Burdick, S. L. Kunkel, R. M. Strieter, and M. Peters-Golden. 1995. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest. 95:1861-1868.